Singapore, March 30 -- In a move reflecting their shared commitment to advancing the healthcare sector and elevating the quality of medical services, Jamjoom Pharma, one of the fastest-growing pharmaceutical companies in the Middle East and Africa, has announced the signing of a strategic Memorandum of Understanding (MoU) with Magrabi Health Group.

The agreement aims to enhance cooperation in ophthalmology, encompassing medical training, health awareness, and the advancement of innovative therapeutic solutions.

This partnership aligns with ongoing efforts to unify medical and pharmaceutical expertise. Both institutions strive to deliver an integrated model that improves the quality of healthcare provided to ophthalmology patients across...